Supporting Information Placeholder
ABSTRACT: A build-couple-pair strategy, including double reductive amination macrocyclisation, has been used to generate decorated macrocycles (Eannaphanes) with an embedded triazole and monosaccharide. Biological screening led to the identification of an inducer of apoptosis in leukemic cells, which acts at least partially as a 5-HT2 antagonist.
Challenges encountered in the discovery of small molecule drugs 1 may be related to a relatively low number of scaffolds or frameworks investigated in medicinal chemistry programmes. 2 In this regard, the development of new macrocyclic scaffolds has been of interest 3, 4 due to a view that there is a lack of macrocyclic scaffolds in screening collections. 5, 6 Motivated to address this, we approached the convergent assembly of a macrocycle, which could be concisely assembled, and facilitate decoration of the scaffold with pharmacophoric groups. The Eannaphane scaffold reported herein contains an amine as well as triazole and saccharide groups, embedded into the macrocycle (1-2; Scheme 1). 7 The synthetic approach was based on assembling building blocks 3-6. It was envisaged that those with the azide and alkyne groups would be first combined using the copper catalysed azide-alkyne cycloaddition to generate a 1,4-triazole and that this would be followed by oxidative cleavage of the alkene groups and subsequent ring closing double reductive amination reactions to give rise to the macrocycle (Scheme 1). Various pharmacophores could be incorporated by placing such groups strategically on 3-6.
The synthesis of the bifunctional saccharide derived building blocks were first worked out. The allyl galactose derivative 7 was selective tosylated at the 6-OH group and subsequent reaction with sodium azide in DMF led to the azide 8. Alkylation of the galactose 2-OH group with a variety of alkyl halides gave 9-12 (Scheme 2). In order to obtain 16 (Scheme 3) that has both alkyne and alkene groups, a TBS group was introduced at the primary alcohol group of 7 to give 14. Next, alkylation, to introduce a pharmacophoric group at the 2-oxygen atom, followed by desilylation to give 15 and subsequent propargylation gave 16. The simpler substrates 17/18, were prepared from the alcohol precursor.
Scheme 1. Retrosynthetic analysis

Scheme 2. Synthesis of 9-12
Preparation of the macrocycles is exemplified in Scheme 4 with the synthesis of 20 and 23 shown. Hence the Cu(I) catalysed azide-alkyne cycloaddition 8 of 10 with 16 gave the 1,4-triazole 19. Oxidative cleavage of the two alkenes of 19 gave a dialdehyde, which provided the macrocycle after double reductive amination cyclisation. This macrocycle with the acetonide protecting groups present can be isolated or the acetonides can be removed to give 20, with three isopentyl groups. The reaction of 10 with 17 gave 21 and oxidative cleavage -double reductive amination ring closing reaction, this time using benzyl amine, gave 22. Acetonide removal from 22 gave 23. (Table 1) are among those to have been prepared by the strategy shown in Scheme 4. The macrocycle is decorated with pharmacophores, such as isopentyl, benzyl, indolylethyl, carboxyl, ethyl and napthylethyl groups. The strategy is relevant to peptidomimetic synthesis given that a number of these pharmacophores correspond to side chains of natural amino acids. Once in hand, a preliminary assessment of selected biological properties of these compounds was carried out. Normal cells (primary human fibroblasts) and cancerous cells (leukemic cells) were treated with the compounds and while normal fibroblasts (non-cancerous cells) were not affected, the viability of Oci-AML2 leukemic cells (cancerous cells) sharply reduced upon exposure to 10 M or higher concentrations of some compounds. The macrocycles with two saccharides (20, 24-33 and their protected derivatives) were generally found to be insoluble in assay conditions above 1 M. However macrocycles with one embedded saccharide such as 22, 23 and 34-38 and their acetonide derivatives had improved solubility and the biological assays were focused on these agents. The more potent were macrocycles decorated with both the isopentyl and naphthylethyl groups such as 38 and 40 and to a lesser extent 35. The effects of 40 on both fibroblasts and Oci-AML2 cells are shown in Figure 1(A) . In order to confirm the potential cytotoxic effect of 40 on leukemic cells, a panel of leukemic cell types were treated with a dosage of 40 and it reduced the viability of all four leukemic cell types by 80-90% compared to the untreated control sample ( Figure 1B) .
Table 1. Examples of Macrocycles Synthesized
This observed reduction in viability could have been due to induction of necrotic cell death or apoptotic cell death or inhibition of cell growth. To identify the mechanism by which 40 reduced viability, Oci-AML2 cells were treated with the compound and cell morphology as well as exposure of the membrane lipid phosphatidyl serine to the outer leaflet of the plasma membrane was monitored using the Annexin V binding assay (Figure 2 ). Compound 40 induced phosphatidyl serine exposure, cell shrinkage and nuclear condensation, all typical events in cells dying through the natural (apoptotic) compound scaffold 9 Compound 40 was next investigated for its inhibition of ligand binding to 55 different receptors 10 and the ability of 40 to displace an agonistic or antagonistic radiolabelled-ligand from each receptor was measured. Several of the hits for 40 in this screening were serotonin receptors (5-HT1A, 5-HT2A, 5-HT2B) and the serotonin transporter and the Ki values are shown in Table 2 . 11 Serotonin has previously been associated with induction of apoptosis in leukemic cells. 12, 13 Primary leukemic cells may express serotonin receptors and the serotonin transporter and serotonin is a survival signal for them. In order to investigate the binding of 40, molecular docking was performed, using MOE. 14 The coordinates for 5-HT2B were available in the RSCB-PDB (4NC3, resolution 2.80Å) and includes a co-crystal with ergotamine (4IB4). 15 Docking of ergotamine was first investigated and the binding pose obtained had almost same binding conformation and interaction as in the co-crystal structure, with a slight deviation of 0.477 Å (RMSD).
Clustering of binding poses of the reference compound mesulergine (RMSD 0.736 Å) and 40 (RMSD 0.952 Å), showed that 40 may be able to display similar binding as the 5-HT2 antagonist (Fig. 3) . For example, there was a π-π stacking interaction of the naphthalene group of 40 (3.80 Å & 3.95 Å) and the benzopyrrole residue of mesulergine (3.43 Å & 3.48 Å) with Phe340. Overall, the comparison of 40 with mesulergine indicates that 40 would utilize a wider volume of the cavity that potentially could be used to facilitate selective inhibitor design. To conclude, we describe an efficient synthesis of a new chiral macrocyclic scaffold, adding to number of available macrocyclic frameworks. The synthesis route enabled the generation of analogues and decoration of the macrocycle in a concise manner. The ring closing double reductive amination macrocyclisation has been rarely used in macrocycle formation 16 and the results shown herein indicate it is worthy of consideration more generally. 17 The utilization of the amine in the final ring-closing step provides an efficient way to expand the number of macrocyclic compounds for screening, given the wide number of available amines. The strategy used herein could potentially contribute to preparation of more macrocyclic scaffolds 18 and follows the build-couple-pair strategy 19 used in diversity-oriented synthesis. Evaluation of a preliminary set of molecules based on the macrocycle has led to identification of a compound selectively toxic to tumour cells and evidence is provided that the apoptosis induced is at least partially due to binding to either the 5-HT2A and/or 5-HT2B receptor. The pharmacology of 5-HT1/2 receptors is complex. The receptors may have ligand-independent activity and the functional efficacy of ligands depends not only on their binding affinity, but the nature of their interaction. The high concentration of 5-HT2-antagonists required to induce cell death indicate that basal, ligand-independent receptor activity is important for cell survival and blockage of this activity may reflect inverse agonistic action of the tested compounds, and not pure antagonism. 20 Full pharmacological investigation is necessary to confirm this. The macrocyclic scaffold and synthetic approach is relevant for medicinal chemistry or chemical biology, leading to bioactive compounds. Investigations are underway to generate more macrocyclic scaffolds by this and related approaches. 
